Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer

Por Moynihan, C., Bancroft, E.K., Mitra, A., Ardern‐Jones, A., Castro, E., Page, E.C., Eeles, R.A.
Publicado no Psychooncology (2017)

Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information

Por Hallowell, N, Foster, C, Eeles, R, Ardern-Jones, A, Murday, V, Watson, M, Clarke, A, Hallowell, N, Watson, M
Publicado em 2003

No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British...

Por Edwards, S. M., Dearnaley, D. P., Ardern-Jones, A., Hamoudi, R. A., Easton, D. F., Ford, D., Shearer, R., Dowe, A., Eeles, R. A.
Publicado em 1997

Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers

Por Kote-Jarai, Z, Salmon, A, Mengitsu, T, Copeland, M, Ardern-Jones, A, Locke, I, Shanley, S, Summersgill, B, Lu, Y-j, Shipley, J, Eeles, R
Publicado em 2006

The G67E mutation in hMLH1 is associated with an unusual presentation of Lynch syndrome

Por Clyne, M, Offman, J, Shanley, S, Virgo, J D, Radulovic, M, Wang, Y, Ardern-Jones, A, Eeles, R, Hoffmann, E, Yu, V P C C
Publicado em 2009

Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators...

Por Dunsmuir, W. D., Edwards, S. M., Lakhani, S. R., Young, M., Corbishley, C., Kirby, R. S., Dearnaley, D. P., Dowe, A., Ardern-Jones, A., Kelly, J., Eeles, R. A.
Publicado em 1998

Apoptosis, ageing and cancer susceptibility

Por Camplejohn, R S, Gilchrist, R, Easton, D, McKenzie-Edwards, E, Barnes, D M, Eccles, D M, Ardern-Jones, A, Hodgson, S V, Duddy, P M, Eeles, R A
Publicado em 2003

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease

Por Meitz, J C, Edwards, S M, Easton, D F, Murkin, A, Ardern-Jones, A, Jackson, R A, Williams, S, Dearnaley, D P, Stratton, M R, Houlston, R S, Eeles, R A
Publicado em 2002

Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations

Por Leegte, B, van der Hout, A H, Deffenbaugh, A, Bakker, M, Mulder, I, ten, B, Leenders, E, Wesseling, J, de Hullu, J, Hoogerbrugge, N, Ligtenberg, M, Ardern-Jones, A, Bancroft, E, Salmon, A, Barwell, J, Eeles, R, Oosterwijk, J
Publicado em 2005

ATM polymorphisms as risk factors for prostate cancer development

Por Angèle, S, Falconer, A, Edwards, S M, Dörk, T, Bremer, M, Moullan, N, Chapot, B, Muir, K, Houlston, R, Norman, A R, Bullock, S, Hope, Q, Meitz, J, Dearnaley, D, Dowe, A, Southgate, C, Ardern-Jones, A, Easton, D F, Eeles, R A, Hall, J
Publicado em 2004

Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators.

Por Eeles, R A, Durocher, F, Edwards, S, Teare, D, Badzioch, M, Hamoudi, R, Gill, S, Biggs, P, Dearnaley, D, Ardern-Jones, A, Dowe, A, Shearer, R, McLennan, D L, Norman, R L, Ghadirian, P, Aprikian, A, Ford, D, Amos, C, King, T M, Labrie, F, Simard, J, Narod, S A, Easton, D, Foulkes, W D
Publicado em 1998

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis

Por Edwards, S M, Evans, D G R, Hope, Q, Norman, A R, Barbachano, Y, Bullock, S, Kote-Jarai, Z, Meitz, J, Falconer, A, Osin, P, Fisher, C, Guy, M, Jhavar, S G, Hall, A L, O'Brien, L T, Gehr-Swain, B N, Wilkinson, R A, Forrest, M S, Dearnaley, D P, Ardern-Jones, A T, Page, E C, Easton, D F, Eeles, R A
Publicado em 2010